Latest News

 Filter by Provider

NetEase stock aligns with Peter Lynch's strategy, showing strong EPS growth, a low PEG ratio, and excellent financial health for long-term investors.

Welding and cutting equipment manufacturer ESAB (NYSE:ESAB) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 8.1% year on year to $727.8 million. Its non-GAAP profit of $1.32 per share was 3.7% above analysts’ consensus estimates.

Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ consensus estimates.

As equity valuations approach the record highs of 1999, investors are growing anxious.

Biotechnology company United Therapeutics (NASDAQ:UTHR) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 6.8% year on year to $799.5 million. Its GAAP profit of $7.16 per share was 2.3% above analysts’ consensus estimates.

Thermo Fisher expects the acquisition to be immediately accretive to its adjusted operating margin.

UMC reported 2.2% decrease in revenue for third quarter, surpassing analyst estimates. Advanced process nodes contributed to growth.

Construction equipment company Caterpillar (NYSE:CAT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $17.64 billion. Its non-GAAP profit of $4.95 per share was 9.4% above analysts’ consensus estimates.

The tide is rising for this cruise stock.

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 5.8% year on year to $5.14 billion. Its non-GAAP profit of $1.07 per share was 2.2% above analysts’ consensus estimates.

Gas handling company Chart (NYSE:GTLS) missed Wall Street’s revenue expectations in Q3 CY2025 as sales rose 3.6% year on year to $1.10 billion. Its non-GAAP profit of $2.78 per share was 11.2% below analysts’ consensus estimates.

Rigel Pharmaceuticals shows explosive growth, strong cash flow, and high ROE, aligning with Louis Navellier's proven stock-picking system for growth investors.

The New Zealand Dollar pulls back from highs near 0.5800 against the USD, but remains above 0.5750.

Applied Digital just signed $16 billion in AI deals -- but Wall Street thinks the best is yet to come. Here's why investors should pay attention now.

Discover how Vertex Pharmaceuticals (VRTX) combines strong fundamentals, like high profitability and no debt, with a bullish technical breakout pattern for potential growth.

IonQ is a leader in one of the tech industry's most promising emerging technologies.

When markets are unpredictable, inflation is persistent, and interest rate policy keeps shifting, it’s natural to feel uneasy about the future of your retirement plan.

Shares of Joby Aviation surged in pre-market trading on Wednesday after the electric air-taxi maker announced a collaboration with Nvidia Corp.

Fresh produce company Fresh Del Monte (NYSE:FDP) fell short of the markets revenue expectations in Q3 CY2025, with sales flat year on year at $1.02 billion. Its non-GAAP profit of $0.69 per share was 38% above analysts’ consensus estimates.

Stride (LRN) offers affordable growth with strong EPS & revenue increases, high profitability, and a reasonable valuation in the expanding EdTech sector.

Tesla CEO Elon Musk reaffirms company's autonomous driving capabilities despite the ongoing NHTSA probe and Robotaxi rollback.

Power generation products company Generac (NYSE:GNRC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5% year on year to $1.11 billion. Its non-GAAP profit of $1.83 per share was 16.7% below analysts’ consensus estimates.

It offers compelling weight-loss drugs -- and a compelling stock price, too.

Bitcoin price remained under pressure on Wednesday morning as investors waited for key events like the Federal Reserve interest rate decision and talks between Donald Trump and Xi Jinping.

Silicon Valley investors commit $100M to chip startup Substrate, aiming to disrupt Taiwan Semiconductor and ASML in advanced chipmaking.

Health coverage company Centene (NYSE:CNC) announced better-than-expected revenue in Q3 CY2025, with sales up 18.2% year on year to $49.69 billion. Its non-GAAP profit of $0.50 per share was significantly above analysts’ consensus estimates.

Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.

This stock has caught fire after some recent events, but how long will that last?

Agriculture products company SiteOne Landscape Supply (NYSE:SITE) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.1% year on year to $1.26 billion. Its GAAP profit of $1.31 per share was 6% above analysts’ consensus estimates.

IMAX stock shows strong technicals and a high-quality consolidation pattern, signaling a potential breakout opportunity for traders.

USD/JPY fell sharply from the ¥153 resistance zone, hinting at a potential double top, with ¥150 emerging as a key support level ahead of major central bank decisions.

South Korea welcomes Donald Trump with a crown, ketchup-themed lunch & highest honor for 'peacemaker' role.

The Sports goods major struck an upbeat tone for 2026, pointing to a packed sporting calendar — including the Winter Olympics and the Football World Cup — as key opportunities for growth.

SSR Mining (SSRM) shows explosive earnings growth up 1,175% and a strong technical breakout pattern, offering a high-growth momentum opportunity.

Palantir's earnings are highly anticipated among investors.

It could be time for mid-caps to finally outpace their larger peers.

A look at the alarming state of Europe’s economy, the decline of major German industries, and the growing influence of digital ID and digital currency across the EU.

The Republican President spoke about the potential deal during the Asia-Pacific Economic Cooperation summit in Gyeongju, South Korea.

The Trump administration has issued a new guidance that could undermine ongoing state efforts to keep medical debt off consumers' credit reports, reversing previous credit protections.

The learning company says challenges with third-party integrations disrupted the platform’s experience, leading to fewer enrollments.

The AI infrastructure provider doesn't want you to know its "true" gross margin.

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

Binance (CRYPTO: BNB) co-founder Changpeng “CZ” Zhao is preparing to file a lawsuit against Sen. Elizabeth Warren (D-Mass.) for alleged defamation related to remarks she made about his conviction, according to a report released Tuesday.

This leading cryptocurrency is going through a rough patch, but can it recover?

Indian share markets are trading higher today, with the Sensex trading 142 points higher, and the Nifty is trading 60 points higher.

U.S. stock futures were fluctuating on Wednesday following Tuesday’s advance. Futures of major benchmark indices were mixed.

Teradyne rose over 23% in pre-market trading after reporting third-quarter revenue at the high end of guidance.

Aircraft manufacturing stocks are benefiting from a supply chain problem in the aviation industry.

It's not the end of the world for the drugmaker.